| |
spa resorts for sale overseas
News and Information Article
Cancer!MPact(TM) Provides a Comprehensive Outlook on the Global Oncology
Marketplace
ST. LOUIS, June 1 // -- The Mattson Jack Group, Inc. (MJG)
announces the launch of Cancer!MPact(TM), the premier source of global
oncology market information. Cancer!MPact(TM) combines the rigorous
epidemiology, detailed clinical analysis, and in-depth market assessment
methodologies from predecessor products CancerMETRIC(R) and Cancer
Perspectives(TM). This new service offers a comprehensive clinical and
market review of the three largest cancer markets: the United States,
Europe (France, Germany, Italy, Spain, and the United Kingdom), and Japan.
"Cancer!MPact(TM) leverages the unparalleled oncology expertise of
DaVinci Oncology Specialists (DaVinci), the cancer center of excellence
within Mattson Jack," said James Hawthorne, MJG Executive Vice President.
"By utilizing the data sources identified as preeminent for each
country/region and the best-in-class methodologies from our prior
services, DaVinci Oncology Specialists has created the most comprehensive
oncology information offering for our clients."
"Cancer!MPact(TM) is the only all-inclusive service that provides a
consistent global methodology and perspective to clients. For example, our
unmatched epidemiology utilizes sources from the largest cancer registries
and databases available and represents our ongoing commitment to our
clients to provide them with the most up-to-date, comprehensive view of the
oncology patient population," said Roger Halualani, Vice President of MJGs
DaVinci Oncology Specialists.
This service comprises four topic areas delivered in five integrated
modules:
-- Patient Metrics: Based on highly rigorous epidemiology modeling
incorporating country-specific data, this module presents historical,
current, and projected estimates to 2025 of cancer incidence,
prevalence, active disease and treated populations by cancer site and
stage.
-- Emerging Technologies: This module evaluates the top emerging products
in the cancer arena and provides detailed profiles that combine the
most recent clinical data with cogent and relative analysis. The
module provides insights into the future marketplace through the
generation of estimated development timelines and indication matrices
to identify where different drugs are being (or not being) developed.
-- Treatment Cascades: Given that Cancer!MPact(TM) treatment data
presents perspectives on the current and possible future clinical
management of cancer, the data is provided in two separate modules:
-- Treatment Architecture: This module provides a detailed view of
the current clinical management of cancer patients by site and
stage and profiles treatment, modality, and chemotherapeutic
regimen utilizing a robust data collection phase with practicing
oncologists across study countries.
-- Treatment Evolution: This module is a unique data source that
provides detailed analysis and insights into the future
development of the oncology marketplace on an indication basis.
By assessing possible treatment trends based on level of impact
and likelihood of occurrence, this module presents DaVincis
expected changes in the marketplace.
-- Market Perspectives: Utilizing the knowledge derived from the four
prior modules combined with sales level data, Market Perspectives
provides detailed estimates of the current oncology market on a
cancer-specific basis, down to a stage, regimen, and drug-specific
level.
"Given the increasing changes in pharmaceutical market, it is critical
for our clients to understand the dynamics of the current and future
oncology markets. This requires taking into account clinical management
trends, novel oncology drugs and regimens, and potential changes in patient
populations," said Ian Hicks, Vice President of MJGs DaVinci Oncology
Specialists, who is responsible for the marketing of DaVincis cancer-based
reports and services. "Cancer!MPact(TM) provides new product development
and brand teams with the insights and knowledge to make informed decisions
regarding positioning and marketing of their cancer products in what has
become an increasingly competitive market."
Cancer!MPact(TM) builds upon the success of MJGs CancerMETRIC(R) and
Cancer Perspectives(TM) offerings, providing pharmaceutical and biotech
executives with critical, across-the-board intelligence to assist them in
making informed decisions about their brands and planned product
development.
Mattson Jacks client list includes some of the most recognized
pharmaceutical and biotech companies in the world. For further information,
contact Amit Dhawan, MD (314) 469-7600 or e-mail: info@mattsonjack.com .
Editors Notes:
About The Mattson Jack Group, Inc.
Formed in 1986, Mattson Jack ( http://www.mattsonjack.com ) focuses its
talent in three areas of Core Competency: Business Analytics, Brand
Optimization, and Corporate Development services in the pharmaceutical and
biotech markets. Its ongoing mission is to "Accelerate Client Growth
through advanced analysis, planning, decision support, and implementation."
MJG consultants have expertise in pricing and reimbursement, custom
epidemiology, technology assessment, business and strategic plan
development, due-diligence and licensing support, market modeling and
forecasting, and primary market research. The high-value non-cancer MJG
products include Epi Database(R) and Forecast Architect(R).
DaVinci Oncology Specialists is the cancer center of excellence within
Mattson Jack and was formed after the acquisition of DaVinci Healthcare
Partners LLC in 2004. The combination of the DaVinci and MJG cancer
specialists resulted in the formation of the worlds largest cancer-focused
consultancy. In addition to Cancer!MPact(TM), DaVinci also offers Oncology
Marketing Strategies(TM), a unique cancer-focused report detailing the
changes in the reimbursement systems for the U.S. and Europe and providing
key implications and recommendations for brand teams regarding customers,
channels, policy, pricing, and reimbursement issues. Other DaVinci reports
include Supportive Care Perspectives(TM), Future Focus(TM) Myelodyplastic
Syndromes (MDS), and Future Focus(TM) Gastrointestinal Stromal Tumor
(GIST).
Mattson Jack is part of Kantar Group, the Information and Consultancy
division within WPP, an $8+ billion global communications services firm.
Kantar is one of the worlds largest research, insight and consultancy
networks. It helps clients make better business decisions through a deeper
understanding of their markets, their brands and their customers. Part of
WPP, Kantar brings together a diverse group of outstanding marketing
insight and consulting companies -- each an expert in their field who can
work together seamlessly to help clients address business issues in a
holistic and strategic way. Kantar companies include: Added Value Group,
AMRB, BMRB, BPRI, Cannondale Associates, Center Partners, Everystone,
Focalyst, Fusion 5, Glendinning Management Consultants, Henley Centre
Headlight Vision, IMRB, KMR Group, Lightspeed Research, Management
Ventures, Mattson Jack Group, Millward Brown, Research International, RMS,
The Operations Centre and Ziment Group. The group operates in 160 offices
across 60 markets worldwide. For further information please visit:
http://www.kantargroup.com .
| |
|
|
 |
spa resorts for sale overseas |
|
|
|
|
|
|
|
|
|
Locations
